Recommendations for Nomenclature of the Insulin-Like Growth Factor Binding Protein Superfamily

Abstract

Kolling Institute of Medical Research (R.C.B.), St. Leonards, New South Wales 2065, Australia; INSERM U142, Hopital Sainte-Antoine (M.A.B.), Paris, France; Department of Medicine, Division of Endocrinology, University of North Carolina School of Medicine (D.R.C.), Chapel Hill, North Carolina 27599-7170; Endocrine Research Unit, Mayo Clinic (C.A.C.), Rochester, Minnesota 55905-0001; Division of Endocrinology, Sophia Children’s Hospital (S.L.S.D.), Rotterdam, Netherlands; Department of Surgery, Bristol Royal Infirmary (J.M.P.H.) Bristol, United Kingdom; Department of Medicine, Loma Linda University (S.M.) Loma Linda, California 92357-0001; Department of Pediatrics, Oregon Health Sciences University (Y.O., R.G.R.) Portland, Oregon 97201